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ABSTRACT
The metastases of the tumor become a serious problem malignancy including 
retinoblastoma. This study aimed to observe the correlation between several 
risk factors with the metastatic status of retinoblastoma patients in Yogyakarta 
Tertiary Hospital. Records of patients with retinoblastoma treated between 2011 
and 2017 were obtained for observational analytic study. The gender, laterality, 
age, Body Mass Index (BMI) classification, BMI for age, type of retinoblastoma, 
and metastatic status were analyzed. The association was statistically analyzed 
by the correlation ratio of Eta test. Thirty-seven cases of retinoblastoma were 
enrolled in this study, with mean age 29.44 (±14.1) months; 14 females and 
23 males. Ten patients (27.0%) have no metastases, while 27 patients (72.9%) 
exhibit metastases. The multivariate logistic regression analysis demonstrated 
that male gender (OR 8.3; 95% CI 1.07–64.5; p = 0.04) and age below 24 months 
(OR 17.6; 95% CI 1.26-248.31; p = 0.03) were a predictive of the metastatic status 
for retinoblastoma. On the other hand, the laterality, BMI classification, BMI 
for age, and types of retinoblastoma were not associated with the metastatic 
status of retinoblastoma. The gender and age were significantly associated 
with the metastatic status of retinoblastoma. Male patients and age below 24 
months were more likely to have metastatic disease of retinoblastoma.
ABSTRAK
Metastasis tumor menjadi masalah serius termasuk retinoblastoma. Penelitian 
ini bertujuan untuk mengamati hubungan antara beberapa faktor risiko dengan 
status metastasis pasien retinoblastoma di Rumah Sakit Tersier Yogyakarta. 
Catatan pasien dengan retinoblastoma yang dirawat antara 2011 dan 2017 
diperoleh untuk studi analitik observasional. Jenis kelamin, lateralitas, usia, 
klasifikasi Indeks Massa Tubuh (IMT), IMT untuk usia, jenis retinoblastoma, 
dan status metastasis dianalisis. Hubungan tersebut dianalisis secara statistik 
dengan rasio korelasi uji Eta. Tiga puluh tujuh kasus retinoblastoma terdaftar 
dalam penelitian ini, dengan usia rata-rata 29,44 (± 14,1) bulan; 14 wanita 
dan 23 pria. Sepuluh pasien (27,0%) tidak memiliki metastasis, sementara 27 
pasien (72,9%) menunjukkan metastasis. Analisis regresi logistik multivariat 
menunjukkan bahwa jenis kelamin laki-laki (OR 8,3; 95% CI 1,07-64,5; p = 0,04) 
dan usia di bawah 24 bulan (OR 17,6; 95% CI 1,26-248,31; p = 0,03) merupakan 
prediksi metastasis status untuk retinoblastoma. Di sisi lain, lateralitas, 
klasifikasi BMI, BMI untuk usia, dan jenis retinoblastoma tidak terkait dengan 
status metastasis retinoblastoma. Jenis kelamin dan usia secara signifikan 
terkait dengan status metastasis retinoblastoma. Pasien pria dan usia di bawah 
24 bulan lebih cenderung memiliki penyakit metastasis retinoblastoma.
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INTRODUCTION
Retinoblastoma is one of Mendelian 
disorders in ophthalmologythat 
transmitted by autosomal dominantmode 
of inheritance.1 Retinoblastoma has 
been reported in many studies as the 
most common primary intraocular 
cancer in children.2-4 Epidemiologic 
studies have shown that, retinoblastoma 
approximately affects 1 in 16.000 to 
18.000 births. While the incidence 
of retinoblastoma has been reported 
around 7000 to 8000 new cases annually 
worldwide.5 Among Asia-Pacific 
countries, Indonesia was included as 
the country that account for 90% of 
retinoblastomas in the Asia-Pacific area.6 
The 2013 data estimates that 43% (3452) 
of the global burden of retinoblastoma 
lives in Asia-Pacific region, and 8% 
(277) of those children were lived in 
Indonesia.7 Accurate diagnosis for 
retinoblastoma can be accomplished by 
a detailed history, physical and ocular 
examination, slit lamp examination, 
and indirect ophthalmoscopy.8 
Recently, ultrasonography showed 
an excellent agreement compared 
with histopathological examination 
as a gold standard examination for 
retinoblastoma.9
A several previous studies 
have shown that there was no sex 
predisposition have been noted for 
retinoblastoma.10-12 However, a male 
predominance has been reported by a 
number of studies in India.13-15 Metastatic 
status of malignancy increases the tumor 
burden and catabolism of endogenous 
substrate reserves becomes more 
profound. Thus, resulting in increasing 
weight loss and compromise of organ 
function which leading to malnutrition 
and cachexia on systemic level.16, 17 
Malnutrition is an underrecognized 
potential complication of cancer in 
children and it has been associated 
with complications, reduced physical 
functioning and decreased survival on 
cancer patients.18,19 Concordantly, several 
studies showed that body mass index 
(BMI) has been reported to plays an 
important role in metastatic malignancy, 
although the molecular mechanism was 
not fully elucidated.20-22 One recent study 
has been postulated a theory, BMI may 
impacts cancer metastatic status with the 
mechanism that involve lipogenesis and 
lipid transport, enhanced vascularity, and 
decreased infiltration of macrophages.23 
The laterality was correlated with the 
type of retinoblastoma and the age 
of presentation. The unilateral cases 
predominantly found in previous studies 
and its reported to be presently late when 
compared to bilateral cases.7,13-15
An understanding whether metastatic 
status of children with retinoblastoma 
and its correlation with several factors 
mentioned above, is a valuable part of 
managing retinoblastoma patients. The 
aim of current study was to evaluate a 
correlation between metastatic state and 
several risk factors in the retinoblastoma 
patients.
MATERIALS AND METHODS 
Patients and data collection
This was analytical observational 
study with cross-sectional design 
that enrolled retinoblastoma patients 
treated at Dr. Sardjito General Hospital 
between 2011 until 2017. The inclusion 
criteria for the study subject including: 
no previous cancer diagnosis, body 
mass index was determined on first 
patient visit, metastatic status was 
determined on first month of patient 
visit. Cases were identified from the 
medical records and body weight, 
height, age, disease classification 
(international retinoblastoma staging 
system), metastatic status, stage of 
retinoblastoma, laterality, symptom 
at presentation, as well as metastatic 
status were obtained. All the patients 
already underwent a surgical removal 
of the tumor and diagnosed based on 
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pathological examination. We found 41 
cases with retinoblastoma. Four cases 
(9.76%) were excluded from analysis 
because insufficient data to confirm 
metastatic status and to calculate body 
mass index at the point of first visit. 
Statistical analysis
The pooled data were analyzed 
using SPSS 23 for Windows. Patients 
characteristics were presented as 
frequencies, mean ± standard deviation 
(SD). Differences between metastatic 
and no metastatic group characteristics 
were analyzed using the Chi-square 
test. Univariate and multivariate logistic 
regression analyses were performed 
with metastatic status as a dependent 
variable to evaluate the association 
between related variables and its odds 
ratio.
RESULTS
The patient’s characteristic was 
shown in TABLE 1. Thirty-seven cases 
of retinoblastoma were enrolled in this 
study, with mean age 29.44 ± 14.1 months 
and consist of 14 females and 23 males. 
The mean of BMI in this study was 16.02 
± 3.52. We also found that the mean of 
gestational age at birth was 38.02 ±1.89. 
The main symptom at the presentation 
was leukocoria (94.6%), while proptosis, 
hyperemic conjunctiva and chemosis 
conjunctiva occurred in at least half of 
the subjects enrolled in this study. We 
also found that most of the tumor had 
invaded the sclera (70.3%). The invasion 
to the lymph node (10.8%) and optic 
nerve (48.6%) were also found in less 
than half of the retinoblastoma patients 
(TABLE 1). 
TABLE 1. Patients’ characteristics.
Characteristic Mean ±SD
Age (months) 29.44±14.1
BMI 16.02±3.52
Gestational age (weeks) 38.02±1.89
Characteristic Frequency (%)
Symptoms
•	 Leukocoria 35 (94.6)
•	 Proptosis 22 (59.5)
•	 Hyperemic conjunctiva 21 (56.8)
•	 Chemosis conjunctiva 19 (51.4)
Invasion
•	 Optic nerve 18 (48.6)
•	 Sclera 26 (70.3)
•	 Lymph nodes 4 (10.8)
Staging
•	 II 10 (27.0)
•	 III 13 (35.1)
•	 IV 14 (37.8)
TABLE 2 has revealed the clinical 
characteristic of the patient in our 
study. Ten (27.1%) patients were found 
to have no metastases, while 27 (72.9%) 
patients exhibit metastases (TABLE 2). 
In general, the metastatic group showed 
similar parameter in terms of laterality, 
age group, BMI classification, BMI for 
age (WHO) and retinoblastoma type. In 
the other hand, male patients showed 
a tendency to had metastatic diseases. 
In the metastatic group the males have 
a proportion of 74.1%, while in non-
metastatic group only 30%. 
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TABLE 2. Patients’ clinical case mix characteristics
Characteristic Total
Metastatic 
(%)
n = 27
Non-
metastatic (%) 
n=10
p OR (95% CI)
Gender
•	 Female 14 7 (25.9) 7 (70)
0.023 6.66 (1.34-33.1)
•	 Male 23 20 (74.1) 3 (30)
Laterality
•	 Unilateral 32 22 (81.5) 10 (100)
0.295 1.45* (1.15-1.84)
•	 Bilateral 5 5 (18.5) 0 (0)
Age Group
•	 Less than 24 months 16 9 (33.3) 7 (70)
0.067 4.66 (0.96-22.4)
•	 More than 24 months 21 18 (66.7) 3 (30)
BMI Classification**
•	 Underweight 31 23 (85.2) 8 (80)
0.653 0.69 (0.11-4.56)
•	 Normal - obese 6 4 (14.8) 2 (20)
BMI for Age (WHO)
•	 Severely wasted 3 2 (7.4) 1 (10)
0.445
•	 Wasted 4 4 (14.8) 0 (0)
•	 Normal 22 16 (59.3) 6 (60)
•	 Overweight 5 3 (11.1) 2 (20)
•	 Obese 3 2 (7.4) 1 (10)
Retinoblastoma Type
•	 Sporadic 26 18 (66.7) 8 (80)
0.688 2.0 (0.35-11.4)
•	 Familial 11 9 (33.3) 2 (20)
* Relative Risk
** BMI Classification = Underweight (<18.5), Normal – Obese (18.5 – 22.9, and >22.9)
of retinoblastoma with the metastatic 
status of retinoblastoma. However, 
none of these factors were significantly 
associated with the metastatic status of 
retinoblastoma, both in univariate as 
well as multivariate analysis. 
TABLE 3. Associations of gender and age 
group with retinoblastoma 
metastasis.
Characteristic
Multivariate
OR (95% CI) p
Gender 8.3 (1.07-64.5) 0.04
Age group 17.6 (1.26-248.31) 0.03
BMI for age (WHO) 0.7 (0.34-1.52) 0.39
Our study showed that the subject’s 
gender significantly correlated with 
the metastatic status of retinoblastoma 
(OR 6.7; 95% CI 1.34–33.1; p = 0.023). 
The multivariate analysis (TABLE 3) 
also showed that gender significantly 
associated with the metastatic status of 
retinoblastoma (OR 8.3; 95% CI 1.07–64.5; 
p = 0.04). While the univariate analysis 
of age group showed a slight significant 
association with metastatic status (OR 
4.7; 95% CI 0.96–22.4; p = 0.067), the 
multivariate analysis (TABLE 3) revealed 
significant association between age 
group with the metastatic status (OR 
17.6; 95% CI 1.26-248.31; p = 0.03). 
We also analyzed the laterality, BMI 
classification, BMI for age (WHO) and type 
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DISCUSSION
To the best of our knowledge, the 
present study is first study reported the 
correlation of several factors that related 
to the metastatic status of retinoblastoma 
in Indonesia. Our findings showed 
that metastatic status has significant 
correlation with gender, in which male 
patients associated with higher risk of 
metastatic disease in retinoblastoma. We 
found no studies available at the moment 
that provides direct comparisons 
with our findings. Other previous 
studies conducted in India revealed 
that there was male preponderance in 
retinoblastoma case.13-15  In the other 
hand, multiple studies suggest that there 
is no race or sex-based predisposition 
to the development of retinoblastoma.24 
Although, a study of epidemiological 
and genetic analyses on sporadic and 
familial retinoblastoma indicate that an 
X-chromosome-linked gene is involved 
in the genesis of a significant fraction 
of new bilateral cases of the disease. 
The activity of this gene results in sex-
ratio distortion in favor of males among 
patients with bilateral sporadic disease.25 
In agreement with these studies, thus, 
our findings suggest that there is an 
increased risk of metastasis in male 
patients. 
The laterality and the type 
of retinoblastoma also shown no 
correlation with the metastatic status of 
retinoblastoma. However, in the current 
study, the age group shows a significant 
association with the metastatic disease 
of retinoblastoma. Previous studies have 
shown that extraocular retinoblastoma 
cases were reported with the mean age 
of patients at presentation was 33 and 
38 months.26, 27 Indeed, other studies also 
mentioned that the risk of metastatic 
disease was higher in patients with 
delayed diagnosis of retinoblastoma.28,29 
While the mean age that presented 
in current study was 29 months, our 
result showed that a patient with 
the age below 24 months was at the 
greater risk for developing metastatic 
disease. In agreement with our study, a 
previous study have shown that there 
are differences in metastasis occurrence 
according to the age group in the Ewing 
sarcoma.30 A study in a zebrafish model 
showed that retinoblastoma cells 
invaded adjacent tissues and spreading 
hematogenously at the early stage 
of tumor.31 This might explain that 
retinoblastoma cells could develop into 
metastatic disease even at the early stage 
of the tumor.
Both BMI classification and BMI 
adjusted for age have no correlation with 
the metastatic status of retinoblastoma. 
These findings were similar to a study 
in 121 children with retinoblastoma 
from Brazil. They found that there 
was no correlation between BMI and 
metastatic status in retinoblastoma 
patients.22 Although, their results at 
point of diagnosis showed that 2.2% 
was underweight, 73.3% had normal 
BMI and 24.4% was overweight. In the 
current study, 31 (83.7%) of the patients 
fall into underweight category. Given 
that poor nutritional status in several 
part of Indonesia, the baseline BMI of 
the patients might attributable to the 
lower BMI of retinoblastoma patients 
in current study. The location of the 
tumor indeed shows a big impact in 
the nutritional status. A previous study 
reported that severe malnutrition was 
more prevalent in cancer of the upper 
gastrointestinal tract (28.3%), while lung 
(10.1%) and breast (5.1%) cancer only 
showed small number of malnutrition 
status.32 Therefore, retinoblastoma 
metastatic status may not affect the 
nutritional status of the patient because 
retinoblastoma primarily found on eye 
and frequent site of metastases were 
bone, lymph node, lung and central 
nervous system which seldom affects 
gastrointestinal organs directly. Thus, 
metastatic status of retinoblastoma 
might be independently associated with 
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the BMI of the patients.
Our findings emphasize that there 
is significant correlation between 
metastatic status and the gender and 
age in retinoblastoma patients, in which 
male patients and the younger age 
patients are at a greater risk to develop 
metastasis disease. To further rule out 
the gender preference and invasiveness 
of tumor that might attributable in 
retinoblastoma pathogenesis, a genetic 
abnormalities examination is necessary. 
The limitation of this study is its cross-
sectional design, which did not allow 
the assessment of the impact of the 
systematic and sequential nutritional 
intervention. Further research may 
be needed with bigger sample size 
in different center, because bigger 
sample size provides opportunities to 
determine the average values of data 
more accurately and avoid misleading 
statistics from testing a small number of 
possibly atypical samples.
CONCLUSSION
The present study demonstrated that 
the gender and age were associated with 
of metastatic status in retinoblastoma 
patients. Male gender and patient 
younger than 24 months old are at the 
higher risk for developing metastatic 
disease of retinoblastoma.
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